328 related articles for article (PubMed ID: 19818004)
1. Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization.
Hsu CY; Huang YH; Su CW; Lin HC; Chiang JH; Lee PC; Lee FY; Huo TI; Lee SD
Liver Int; 2010 Jan; 30(1):77-84. PubMed ID: 19818004
[TBL] [Abstract][Full Text] [Related]
2. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.
Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD
J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study.
Huo TI; Wu JC; Lee PC; Chang FY; Lee SD
Liver Int; 2004 Jun; 24(3):210-5. PubMed ID: 15189271
[TBL] [Abstract][Full Text] [Related]
4. Transarterial chemoembolization in patients with hepatocellular carcinoma and renal insufficiency.
Hsu CY; Huang YH; Su CW; Chiang JH; Lin HC; Lee PC; Lee FY; Huo TI; Lee SD
J Clin Gastroenterol; 2010 Sep; 44(8):e171-7. PubMed ID: 20048685
[TBL] [Abstract][Full Text] [Related]
5. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome.
Huo TI; Wu JC; Huang YH; Chiang JH; Lee PC; Chang FY; Lee SD
Aliment Pharmacol Ther; 2004 May; 19(9):999-1007. PubMed ID: 15113367
[TBL] [Abstract][Full Text] [Related]
6. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.
O'Suilleabhain CB; Poon RT; Yong JL; Ooi GC; Tso WK; Fan ST
Br J Surg; 2003 Mar; 90(3):325-31. PubMed ID: 12594668
[TBL] [Abstract][Full Text] [Related]
7. Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey.
Huo T; Huang YH; Wu JC; Chiang JH; Lee PC; Chang FY; Lee SD
Aliment Pharmacol Ther; 2004 Jun; 19(12):1301-8. PubMed ID: 15191512
[TBL] [Abstract][Full Text] [Related]
8. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].
Kang IK; Kim SW; Hahn SH; Cho SC; Gham CW; Lee DH
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):189-200. PubMed ID: 12499805
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
Yang MJ; An SY; Moon EJ; Lee MS; Hwang JA; Cheong JY; Won JH; Kim JK; Wang HJ; Cho SW
Korean J Hepatol; 2009 Dec; 15(4):474-85. PubMed ID: 20037266
[TBL] [Abstract][Full Text] [Related]
10. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
[TBL] [Abstract][Full Text] [Related]
12. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
[TBL] [Abstract][Full Text] [Related]
13. Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization.
Shen H; Agarwal D; Qi R; Chalasani N; Liangpunsakul S; Lumeng L; Yoo H; Kwo P
Aliment Pharmacol Ther; 2007 Aug; 26(3):393-400. PubMed ID: 17635374
[TBL] [Abstract][Full Text] [Related]
14. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma.
Bayraktar Y; Balkanci F; Kayhan B; Uzunalimoglu B; Gokoz A; Ozisik Y; Gurakar A; Van Thiel DH; Firat D
Hepatogastroenterology; 1996; 43(9):681-7. PubMed ID: 8799415
[TBL] [Abstract][Full Text] [Related]
15. Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis.
Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Pai JT; Loong CC; Chiou YY; Lee RC; Lee FY; Huo TI; Lee SD
Ann Surg Oncol; 2012 Mar; 19(3):842-9. PubMed ID: 21913008
[TBL] [Abstract][Full Text] [Related]
16. Chemoembolization in patients at high risk: results and complications.
Kiely JM; Rilling WS; Touzios JG; Hieb RA; Franco J; Saeian K; Quebbeman EJ; Pitt HA
J Vasc Interv Radiol; 2006 Jan; 17(1):47-53. PubMed ID: 16415132
[TBL] [Abstract][Full Text] [Related]
17. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
Lee HS; Kim JS; Choi IJ; Chung JW; Park JH; Kim CY
Cancer; 1997 Jun; 79(11):2087-94. PubMed ID: 9179054
[TBL] [Abstract][Full Text] [Related]
18. Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
Hsu CY; Huang YH; Chiou YY; Su CW; Lin HC; Lee RC; Chiang JH; Huo TI; Lee FY; Lee SD
Liver Transpl; 2011 May; 17(5):556-66. PubMed ID: 21506244
[TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma.
Huo TI; Hsu CY; Huang YH; Hsia CY; Lin HC; Lee PC; Loong CC; Chiang JH; Chiou YY; Lee SD
Liver Int; 2010 Feb; 30(2):198-207. PubMed ID: 19849777
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for death in 224 cases of hepatocellular carcinoma after transcatheter arterial chemoembolization.
Hiraoka A; Horiike N; Yamashita Y; Koizumi Y; Doi H; Yamamoto Y; Ichikawa S; Hasebe A; Yano M; Miyamoto Y; Ninomiya T; Ootani H; Takamura K; Kawasaki H; Otomi Y; Kogame M; Sogabe I; Ishimaru Y; Kashihara K; Miyagawa M; Hirooka M; Hiasa Y; Matsuura B; Michitaka K; Onji M
Hepatogastroenterology; 2009; 56(89):213-7. PubMed ID: 19453060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
